Literature DB >> 12692703

Platinum determination by inductively coupled plasma-sector field mass spectrometry (ICP-SFMS) in different matrices relevant to human biomonitoring.

S Hann1, G Koellensperger, K Kanitsar, G Stingeder, M Brunner, B Erovic, M Müller, C Reiter.   

Abstract

The analytical challenges of Pt determination by ICP-SFMS posed by different human tissues and fluids have been critically assessed. Investigated samples were (1) urine, (2) serum of cancer patients sampled during chemotherapy with carboplatin, (3) microdialysates (20 micro L sample volume) collected from tumor and non-tumor tissue, and, finally-for the first time-(4) human lung tissue to study background concentrations of inhaled platinum. Sample preparation involved microwave digestion and open vessel treatment or simple dilution (microdialysates). Depending on the sample preparation and introduction systems used (microconcentric nebulization, ultrasonic nebulization with and without membrane desolvation) excellent procedural detection limits (3s criterion) of 0.35 pg g(-1) for urine, 420 pg g(-1) for serum, 400 pg g(-1) for lung tissue and 13 pg g(-1) for microdialysates could be obtained. Ultratrace concentrations of 1-40 pg g(-1), and 1000-3000 pg g(-1) were measured in urine and human lung tissue, respectively, as typical for samples in environmental studies. Quantification was carried out by IDMS and standard addition in the case of urine samples. Internal standardization could not correct for non-spectral interferences in external calibration. In the serum and microdialysates of patients during chemotherapy with carboplatin, elevated Pt levels ranging between 0.01 and 10 micro g g(-1) were determined by external calibration ((195)Pt isotope). For all investigated samples spectral interferences could be excluded by following different strategies. High-resolution control measurements ((194)Pt, (195)Pt) were performed in the case of elevated Pt levels, i.e. for microdialysates and serum samples. An Hf/Pt ratio of 0.4 was determined in human lung samples. An HfO formation ratio of 0.2% was assessed for standard solutions at the present experimental conditions, revealing that the contribution of (179)Hf(16)O, (178)Hf(17)O, (177)Hf(18)O to the (195)Pt isotope signal used for quantification was not significant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692703     DOI: 10.1007/s00216-003-1861-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer.

Authors:  Manijeh Goldberg; Aaron Manzi; Peter Conway; Stefanie Cantin; Vasudha Mishra; Alka Singh; Alexander T Pearson; Eric R Goldberg; Sam Goldberger; Benjamin Flaum; Rifat Hasina; Nyall R London; Gary L Gallia; Chetan Bettegowda; Sonya E O'Neill; Erkin Aydin; Alex Zhavoronkov; Anxo Vidal; Atenea Soto; Maria Jose Alonso; Ari J Rosenberg; Mark W Lingen; Anil D'Cruz; Nishant Agrawal; Evgeny Izumchenko
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

2.  Attomole-per Cell Atomic Mass Spectrometry Measurement of Platinum and Gold Drugs in Cultured Lung Cancer Cells.

Authors:  Wioletta Jakubczak; Maja Haczyk-Więcek; Katarzyna Pawlak
Journal:  Molecules       Date:  2021-12-16       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.